Showing results (231-240 of 427) with videos related to

Sort By:
Pageof 43
Cancer|June 22, 2011
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drugRoberto Latagliata, Antonio Spadea, Michele Cedrone, et al.
Annals of Hematology|October 1, 2016
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinionMassimo Breccia, Patrizia Pregno, Paolo Spallarossa, et al.
Frontiers in Oncology|December 4, 2025
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologistsMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.
Oncotarget|May 19, 2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patientsMaria Rosaria Ricciardi, Valentina Salvestrini, Roberto Licchetta, et al.
Journal of Hematology & Oncology|December 6, 2019
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paperSimona Soverini, Elisabetta Abruzzese, Monica Bocchia, et al.
Critical Reviews in Oncology/Hematology|January 11, 2014
Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11-12, 2013Massimo Breccia, Giuliana Alimena, Michele Baccarani, et al.
Annals of Hematology|March 7, 2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patientsEmilia Scalzulli, Giovanni Caocci, Fabio Efficace, et al.
Frontiers in Oncology|February 24, 2025
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasmsEsther Natalie Oliva, Shien Guo, Jennifer Lord-Bessen, et al.
Cell Communication and Signaling : CCS|April 11, 2025
A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemiaValeria Bica, Veronica Venafra, Giorgia Massacci, et al.
Pageof 43